Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aiko Maejima

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Chemotherapy for recurrent ovarian cancer]Aiko Maejima, Noriyuki Katsumata
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Pertuzumab+trastuzumab+DTX therapy]Aiko Maejima, Kenji Tamura
International Journal of Clinical Oncology|March 23, 2022
The clinical significance of perioperative inflammatory index as a prognostic factor for patients with retroperitoneal soft tissue sarcomaYoshiyuki Matsui, Ayumu Matsuda, Aiko Maejima, et al.
International Journal of Surgery Case Reports|May 15, 2018
Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case reportYoshiyuki Nagumo, Aiko Maejima, Yuta Toyoshima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 17, 2022
[A Survey on the Concomitant Use of Drugs with Enzalutamide in Medical Practice-The Effects and Resultant Decrease in Efficacy]Satoko Arai, Keiichi Koido, Aiko Maejima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 22, 2021
Prognostic implication of staging of seminal vesicle invasion in patients with prostatic adenocarcinoma after prostatectomyArinobu Fukunaga, Aiko Maejima, Yasuo Shinoda, et al.
Japanese Journal of Clinical Oncology|August 1, 2019
Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypesEisuke Kobayashi, Yoichi Naito, Naofumi Asano, et al.
Journal of Chemotherapy (Florence, Italy)|January 12, 2023
Impact of relative dose intensity of trabectedin with pegfilgrastim support: a single-centre retrospective studyYoshimasa Saito, Tatsunori Shimoi, Shintaro Iwata, et al.
Annals of Surgical Oncology|September 8, 2018
Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell TumorYuta Toyoshima, Tomohiko Hara, Yoshiyuki Matsui, et al.
IJU Case Reports|March 7, 2022
Cytoreductive robot-assisted prostatectomy for systemic prostate rhabdomyosarcoma presenting as urinary retentionTakahiro Kirisawa, Arinobu Fukunaga, Hajime Takamori, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Chemotherapy for recurrent ovarian cancer]Aiko Maejima, Noriyuki Katsumata
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Pertuzumab+trastuzumab+DTX therapy]Aiko Maejima, Kenji Tamura
International Journal of Clinical Oncology|March 23, 2022
The clinical significance of perioperative inflammatory index as a prognostic factor for patients with retroperitoneal soft tissue sarcomaYoshiyuki Matsui, Ayumu Matsuda, Aiko Maejima, et al.
International Journal of Surgery Case Reports|May 15, 2018
Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case reportYoshiyuki Nagumo, Aiko Maejima, Yuta Toyoshima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 17, 2022
[A Survey on the Concomitant Use of Drugs with Enzalutamide in Medical Practice-The Effects and Resultant Decrease in Efficacy]Satoko Arai, Keiichi Koido, Aiko Maejima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 22, 2021
Prognostic implication of staging of seminal vesicle invasion in patients with prostatic adenocarcinoma after prostatectomyArinobu Fukunaga, Aiko Maejima, Yasuo Shinoda, et al.
Japanese Journal of Clinical Oncology|August 1, 2019
Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypesEisuke Kobayashi, Yoichi Naito, Naofumi Asano, et al.
Journal of Chemotherapy (Florence, Italy)|January 12, 2023
Impact of relative dose intensity of trabectedin with pegfilgrastim support: a single-centre retrospective studyYoshimasa Saito, Tatsunori Shimoi, Shintaro Iwata, et al.
Annals of Surgical Oncology|September 8, 2018
Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell TumorYuta Toyoshima, Tomohiko Hara, Yoshiyuki Matsui, et al.
IJU Case Reports|March 7, 2022
Cytoreductive robot-assisted prostatectomy for systemic prostate rhabdomyosarcoma presenting as urinary retentionTakahiro Kirisawa, Arinobu Fukunaga, Hajime Takamori, et al.
Pageof 3